Insider Transactions in Q3 2024 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,831
+11.17%
|
$91,324
$4.38 P/Share
|
|
Sep 16
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
30,000
-30.71%
|
$360,000
$12.97 P/Share
|
|
Sep 13
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
65,000
-39.96%
|
$845,000
$13.47 P/Share
|
|
Aug 28
2024
|
Torben Lund Hansen SVP & CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-58.41%
|
$750,000
$15.37 P/Share
|
|
Aug 28
2024
|
Torben Lund Hansen SVP & CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.87%
|
$200,000
$4.38 P/Share
|
|
Aug 26
2024
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-14.04%
|
$70,000
$14.69 P/Share
|
|
Jul 12
2024
|
Peter P. Pfreundschuh CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
46,000
+50.0%
|
-
|